Drawing for MOLECULAR YOU

USPTO serial 87315436

MOLECULAR YOU

Reviewed by CopyMark Law Group

Reg. 6331284Status 700Renewal
Filing date
Status date
Registration date
Apr 27, 2021
Examiner
REINHART, MEGHAN M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MOLECULAR YOU?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey A. Smith

Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.2200 Clarendon BoulevardSuite 1400Arlington, VA 22201

Goods and services

ClassDescriptionStatusFirst use
009Downloadable and recorded computer software for recording, analysis, storage and organization of genetic, proteomic, metabolomic, and microbiomic scientific research and testing data; Downloadable and recorded computer software for providing access to multiple databases that contain aggregated and integrated results of genetic, proteomic, metabolomic, and microbiomic testing; Downloadable publications, namely, electronic reports, articles, bulletins, newsletters and magazines in the fields of molecular analytics, genetic, proteomic, metabolomic, microbiomic and other molecular analytics testing, screening, phenotyping, and ancestry; Computer software for data acquisition and reporting; Kits for use in molecular analytics and genetic, proteomic, metabolomic, and microbiomic and other molecular analytics testing comprising blood, urine, fecal and saliva collection systems comprised of vials, swabs, collection bags, absorptive material for sample collection, and collection containers for blood, urine, feces and saliva, all for non-medical, laboratory use; Kits for blood collection, urine collection, saliva collection and fecal collection for use in molecular analytics and genetic, proteomic, metabolomic, microbiomic testing comprised of vials, swabs, collection bags, absorptive material for sample collection, and collection containers for blood, urine, feces and saliva, all for non-medical, laboratory useACTIVE—
010Kits for use in molecular analytics and genetic, proteomic, metabolomic, and microbiomic and other molecular analytics testing comprising blood, urine, fecal and saliva collection systems comprised of vials, swabs, collection bags, absorptive material for sample collection, and collection containers for blood, urine, feces and saliva, all for medical use; Kits for blood collection, urine collection, saliva collection and fecal collection for use in molecular analytics and genetic, proteomic, metabolomic, microbiomic testing comprised of vials, swabs, collection bags, absorptive material for sample collection, and collection containers for blood, urine, feces and saliva, all for medical useACTIVE—
038Providing online access to databases in the fields of molecular analytics and genetic, proteomic, metabolomic, microbiomic and other molecular analytics testingACTIVE—
042Providing online services in the nature of software as a services (SAAS) services featuring software for use in data management, data storage, data analysis, and report generation, all in the fields of molecular analytics, genetic, proteomic, metabolomic, microbiomic and other molecular analytics testing, screening, genotyping, phenotyping, and ancestry; Providing scientific analysis and informational reports based upon results of laboratory testing in the field of genetic, proteomic, metabolomic, and microbiomic data analytics; Scientific research in the fields of genetic, proteomic, metabolomic, and microbiomic testing; Providing scientific analysis of genetic, proteomic, metabolomic, and microbiomic testing data for scientific research purposes all based upon results of laboratory testing in the field of genetic, proteomic, metabolomic, environmental and microbiomic testing; Providing online computer databases featuring genetics information, based on aggregated results of genotyping, related to genetic, proteomic, metabolomic, microbiomic and other molecular data analytics, for scientific research purposes; Providing online computer databases featuring genetics information for health, fitness and medical purposes all based on aggregated results of genotyping and all for use in connection with scientific or laboratory purposesACTIVE—
044Providing informational reports for health-related purposes based upon results of laboratory testing in the field of genetics; Providing online computer databases featuring health-related and genetics information for health, fitness and medical purposes all based on aggregated results of genotyping, none of the aforementioned for scientific or laboratory purposes; Providing informational reports for consumers on medical conditions, symptoms, treatments, health and general wellness in the field of medicine related to molecular analytics, genetic, proteomic, metabolomic, and microbiomic testing and based upon responses to consumer user surveys, and aggregated information, and user-contributed data therefrom; Providing online computer databases featuring medical information based on aggregated information and user-contributed data from responses to consumer surveys on medical conditions, symptoms, treatment, health and general wellness in the field of medicine, health maintenance, wellness and betterment as it relates to the field of molecular analytics, genetic, proteomic, metabolomic, and microbiomic testing; Medical monitoring and reporting services in the nature of providing consumer informational reports featuring registered users' medical conditions, symptoms, treatments, health and general wellness and all in the field of molecular analytics, genetic, proteomic, metabolomic, and microbiomic testing based upon responses to consumer surveys; Providing online computer databases featuring health information for health, fitness and medical purposes all based on aggregated results of genotyping and all for use in connection with scientific or laboratory purposesACTIVE—
045Online social networking in the fields of molecular analyticsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 27, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 27, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 5, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 5, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jan 5, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 5, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 5, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 29, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 29, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 29, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 29, 2020EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 29, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 29, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 29, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 9, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 9, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 8, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 10, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 10, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 10, 2019CNSISUSPENSION INQUIRY WRITTEN—
Dec 10, 2019RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jun 10, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 10, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jun 10, 2019CNSLSUSPENSION LETTER WRITTEN—
Jun 10, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 3, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Dec 4, 2018GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Dec 4, 2018GNSIINQUIRY TO SUSPENSION E-MAILED—
Dec 4, 2018CNSISUSPENSION INQUIRY WRITTEN—
Dec 3, 2018RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
May 25, 2018RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 24, 2018ALIEASSIGNED TO LIE—
Nov 8, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 8, 2017GNSLLETTER OF SUSPENSION E-MAILED—
Nov 8, 2017CNSLSUSPENSION LETTER WRITTEN—
Nov 1, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 31, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 1, 2017GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
May 1, 2017GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
May 1, 2017EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
May 1, 2017CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Apr 21, 2017DOCKASSIGNED TO EXAMINER—
Jan 31, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 30, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance